192 related articles for article (PubMed ID: 31888000)
1. Actively Targeted and Redox Responsive Delivery of Anticancer Drug by Chitosan Nanoparticles.
Mazzotta E; De Benedittis S; Qualtieri A; Muzzalupo R
Pharmaceutics; 2019 Dec; 12(1):. PubMed ID: 31888000
[TBL] [Abstract][Full Text] [Related]
2. Redox-Responsive and Dual-Targeting Hyaluronic Acid-Methotrexate Prodrug Self-Assembling Nanoparticles for Enhancing Intracellular Drug Self-Delivery.
Zhang Y; Li Y; Tian H; Zhu Q; Wang F; Fan Z; Zhou S; Wang X; Xie L; Hou Z
Mol Pharm; 2019 Jul; 16(7):3133-3144. PubMed ID: 31198046
[TBL] [Abstract][Full Text] [Related]
3. Redox-Responsive Gold Nanoparticles Coated with Hyaluronic Acid and Folic Acid for Application in Targeting Anticancer Therapy.
Munderere R; Gulfam M; Ali I; Kim SH; Vu TT; Park SH; Lim KT
Molecules; 2024 Mar; 29(7):. PubMed ID: 38611843
[TBL] [Abstract][Full Text] [Related]
4. Development of both methotrexate and mitomycin C loaded PEGylated chitosan nanoparticles for targeted drug codelivery and synergistic anticancer effect.
Jia M; Li Y; Yang X; Huang Y; Wu H; Huang Y; Lin J; Li Y; Hou Z; Zhang Q
ACS Appl Mater Interfaces; 2014 Jul; 6(14):11413-23. PubMed ID: 24977925
[TBL] [Abstract][Full Text] [Related]
5. Inclusion of a pH-responsive amino acid-based amphiphile in methotrexate-loaded chitosan nanoparticles as a delivery strategy in cancer therapy.
Nogueira DR; Scheeren LE; Macedo LB; Marcolino AI; Pilar Vinardell M; Mitjans M; Rosa Infante M; Farooqi AA; Rolim CM
Amino Acids; 2016 Jan; 48(1):157-68. PubMed ID: 26306845
[TBL] [Abstract][Full Text] [Related]
6. Decoration of gold nanoparticles with thiolated pH-responsive polymeric (PEG-b-p(2-dimethylamio ethyl methacrylate-co-itaconic acid) shell: A novel platform for targeting of anticancer agent.
Ghorbani M; Hamishehkar H
Mater Sci Eng C Mater Biol Appl; 2017 Dec; 81():561-570. PubMed ID: 28888010
[TBL] [Abstract][Full Text] [Related]
7. Glucose cryoprotectant affects glutathione-responsive antitumor drug release from polysaccharide nanoparticles.
Curcio M; Blanco-Fernández B; Costoya A; Concheiro A; Puoci F; Alvarez-Lorenzo C
Eur J Pharm Biopharm; 2015 Jun; 93():281-92. PubMed ID: 25917641
[TBL] [Abstract][Full Text] [Related]
8. Methotrexate-conjugated chitosan-grafted pH- and thermo-responsive magnetic nanoparticles for targeted therapy of ovarian cancer.
Fathi M; Barar J; Erfan-Niya H; Omidi Y
Int J Biol Macromol; 2020 Jul; 154():1175-1184. PubMed ID: 31730949
[TBL] [Abstract][Full Text] [Related]
9. Dual-targeting nanoparticles with core-crosslinked and pH/redox-bioresponsive properties for enhanced intracellular drug delivery.
Zhao J; Yan C; Chen Z; Liu J; Song H; Wang W; Liu J; Yang N; Zhao Y; Chen L
J Colloid Interface Sci; 2019 Mar; 540():66-77. PubMed ID: 30634060
[TBL] [Abstract][Full Text] [Related]
10. Preparation and In Vitro/In Vivo Characterization of Polymeric Nanoparticles Containing Methotrexate to Improve Lymphatic Delivery.
Jang JH; Jeong SH; Lee YB
Int J Mol Sci; 2019 Jul; 20(13):. PubMed ID: 31284483
[TBL] [Abstract][Full Text] [Related]
11. Dually folate/CD44 receptor-targeted self-assembled hyaluronic acid nanoparticles for dual-drug delivery and combination cancer therapy.
Song L; Pan Z; Zhang H; Li Y; Zhang Y; Lin J; Su G; Ye S; Xie L; Li Y; Hou Z
J Mater Chem B; 2017 Sep; 5(33):6835-6846. PubMed ID: 32264333
[TBL] [Abstract][Full Text] [Related]
12. Preparation, Characterization, and Optimization of Folic Acid-Chitosan-Methotrexate Core-Shell Nanoparticles by Box-Behnken Design for Tumor-Targeted Drug Delivery.
Naghibi Beidokhti HR; Ghaffarzadegan R; Mirzakhanlouei S; Ghazizadeh L; Dorkoosh FA
AAPS PharmSciTech; 2017 Jan; 18(1):115-129. PubMed ID: 26896317
[TBL] [Abstract][Full Text] [Related]
13. Methotrexate-loaded PEGylated chitosan nanoparticles: synthesis, characterization, and in vitro and in vivo antitumoral activity.
Chen J; Huang L; Lai H; Lu C; Fang M; Zhang Q; Luo X
Mol Pharm; 2014 Jul; 11(7):2213-23. PubMed ID: 24164427
[TBL] [Abstract][Full Text] [Related]
14. Enhanced Cellular Internalization and On-Demand Intracellular Release of Doxorubicin by Stepwise pH-/Reduction-Responsive Nanoparticles.
Li F; Chen WL; You BG; Liu Y; Yang SD; Yuan ZQ; Zhu WJ; Li JZ; Qu CX; Zhou YJ; Zhou XF; Liu C; Zhang XN
ACS Appl Mater Interfaces; 2016 Nov; 8(47):32146-32158. PubMed ID: 27933846
[TBL] [Abstract][Full Text] [Related]
15. In vitro antitumor activity of methotrexate via pH-sensitive chitosan nanoparticles.
Nogueira DR; Tavano L; Mitjans M; Pérez L; Infante MR; Vinardell MP
Biomaterials; 2013 Apr; 34(11):2758-72. PubMed ID: 23352041
[TBL] [Abstract][Full Text] [Related]
16. Actively targeted delivery of anticancer drug to tumor cells by redox-responsive star-shaped micelles.
Shi C; Guo X; Qu Q; Tang Z; Wang Y; Zhou S
Biomaterials; 2014 Oct; 35(30):8711-22. PubMed ID: 25002267
[TBL] [Abstract][Full Text] [Related]
17. Simply constructed chitosan nanocarriers with precise spatiotemporal control for efficient intracellular drug delivery.
Kong M; Zuo Y; Wang M; Bai X; Feng C; Chen X
Carbohydr Polym; 2017 Aug; 169():341-350. PubMed ID: 28504154
[TBL] [Abstract][Full Text] [Related]
18. Validation of a Janus role of methotrexate-based PEGylated chitosan nanoparticles in vitro.
Luo F; Li Y; Jia M; Cui F; Wu H; Yu F; Lin J; Yang X; Hou Z; Zhang Q
Nanoscale Res Lett; 2014; 9(1):363. PubMed ID: 25114653
[TBL] [Abstract][Full Text] [Related]
19. Novel Chitosan Nanoparticles Loaded with Methotrexate for Topical Treatment of Psoriasis.
Al-Nemrawi NK; Khafajah AS; Alzoubi KH
Pharm Nanotechnol; 2023; 11(5):460-474. PubMed ID: 37132113
[TBL] [Abstract][Full Text] [Related]
20. Graft copolymer nanoparticles with pH and reduction dual-induced disassemblable property for enhanced intracellular curcumin release.
Zhao J; Liu J; Xu S; Zhou J; Han S; Deng L; Zhang J; Liu J; Meng A; Dong A
ACS Appl Mater Interfaces; 2013 Dec; 5(24):13216-26. PubMed ID: 24313273
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
